| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912170 | Multiple Sclerosis and Related Disorders | 2016 | 32 Pages |
Abstract
The results of this 2-year study demonstrate that IM IFN beta-1a can be used effectively and safely in Japanese patients with relapsing-remitting multiple sclerosis for an extended period of time.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Takahiko Saida, Jun-ichi Kira, Yasuhiro Ueno, Naozumi Harada, Toshiyuki Hirakata,